Fengting Su
Impact in
- Geriatrics and Gerontology top 10%
- Sirtuins and Resveratrol in Medicine
Papers in
-
- Ubiquitin and proteasome pathways 3
- Histone Deacetylase Inhibitors Research 2
- Metabolism, Diabetes, and Cancer 1
-
- Sirtuins and Resveratrol in Medicine 3
- Co-authors
- Andreas Koeberle (4 shared papers)Xiaolong Tang (4 shared papers)Baohua Liu (4 shared papers)Zuojun Liu (3 shared papers)Minxian Qian (3 shared papers)Meng Yuan (2 shared papers)Lei Shi (2 shared papers)Jie Sun (2 shared papers)
In The Last Decade
Fengting Su
9 papers receiving 254 citations
Peers
Comparison fields: 5 of 68
- Geriatrics and Gerontology 34
- Physiology 16
- Cancer Research 48
- Molecular Biology 138
- Endocrinology, Diabetes and Metabolism 30
Countries citing papers authored by Fengting Su
This map shows the geographic impact of Fengting Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengting Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengting Su more than expected).
Fields of papers citing papers by Fengting Su
This network shows the impact of papers produced by Fengting Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengting Su. The network helps show where Fengting Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Fengting Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 75 | |
| 2 | 2023 | 52 | |
| 3 | 2021 | 46 | |
| 4 | 2018 | 45 | |
| 5 | 2015 | 12 | |
| 6 | 2021 | 11 | |
| 7 | 2021 | 9 | |
| 8 | 2024 | 5 | |
| 9 | 2025 | 1 |
About Fengting Su
Fengting Su is a scholar working on Molecular Biology, Geriatrics and Gerontology, Pulmonary and Respiratory Medicine, Cancer Research and Surgery, having authored 9 papers that have together received 256 indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (3 papers), Ubiquitin and proteasome pathways (3 papers), Histone Deacetylase Inhibitors Research (2 papers), Cancer, Lipids, and Metabolism (2 papers), Metabolism, Diabetes, and Cancer (1 paper), Particle Dynamics in Fluid Flows (1 paper), Computational Drug Discovery Methods (1 paper) and Cholesterol and Lipid Metabolism (1 paper). The work is most often cited by research in Geriatrics and Gerontology (34 citations), Physiology (16 citations), Cancer Research (48 citations), Molecular Biology (138 citations) and Endocrinology, Diabetes and Metabolism (30 citations). Fengting Su has collaborated with scholars based in China, Austria and Germany. Frequent co-authors include Andreas Koeberle, Xiaolong Tang, Baohua Liu, Zuojun Liu, Minxian Qian, Meng Yuan, Lei Shi, Jie Sun, Ji Li and Li Guo. Their work appears in journals such as Nature Communications, Circulation Research, Communications Biology, Theranostics and Particuology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.